Individuals Coming Off Slimming Injections Regain Pounds Far More Rapidly Than Dieters

A recent study reveals that people who come off new weight-loss injections like Mounjaro or Wegovy may regain lost weight much more quickly than those who stop traditional diet and exercise programs.

Published data in a major medical journal points out that while obese individuals can lose a large proportion of their body weight while undergoing treatment, the weight returns at an estimated rate of 0.8 kg per month upon discontinuation.

"Individuals purchasing such treatments should be cognizant of the potential of rapid weight regain when the treatment concludes," warns lead investigator Dr. Susan Jebb.

That rate of recovery suggests a return to original mass within about a year and a half.

Weighing Approaches

The study, which examined 37 of trials involving thousands of patients, compared the effects of these new drugs with conventional dieting.

Researchers point out that people who shed pounds through diet and exercise usually have a less rapid creep back—around 0.1 kg a month—after stopping.

Understanding the Quick Rebound

Nutrition scientists believe the mechanism of the jabs accounts for the amplified rebound.

These medications copy a natural hormone called glucagon-like peptide-1, which helps regulate appetite.

"Sustained high doses of the hormone levels far above than normal might result in the system to produce less of its endogenous hormone, and could diminish responsiveness to its effects," said Dr. Adam Collins, a nutrition specialist.

"Discontinuation of this hormone supplement leads to appetite is unsuppressed, making excessive eating far more likely."

An Ongoing Issue?

Health authorities recommend the jabs for individuals with obesity-related health risks, accompanied by prescribed lifestyle changes.

Professionals argue that, due to the significant potential of weight regain, the therapy is often long-term.

This view is supported by pharmaceutical companies, who say that the findings "emphasize the long-term character of excess weight," comparing it to managing conditions like hypertension.

User Testimonies

Users who have stopped the medication report a intense return of hunger.

"It was like a trigger that goes on and you become starving," said one woman.

The struggle is exacerbated if individuals have not established permanent lifestyle or habit modifications during therapy.

Widespread Adoption

Survey data show that a significant number of people in the UK have used weight-loss jabs in the past year, with demand remaining high.

• Use is greater among women than men.
• The 40s and 50s age group shows the greatest level of interest.
• Many access the medications through private healthcare rather than public health services.

In conclusion, experts stress that while GLP-1 drugs are effective agents for shedding pounds, they are not a permanent solution and long-term success hinges on integrated behavioural management.